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Correction, Vol. 8, No. 1
In the article “Antimicrobial Sensitivity in Enterobacteria from
AIDS Patients, Zambia,” by James Mwansa et al., errors were made
in calculations for the table on page 93. The corrected table appears
below and online at http://www.cdc.gov/ncidod/eid/vol8no1/01-
0018.htm. We regret any confusion these errors may have caused.
Correction, Vol. 8, No. 4
In “Antimicrobial Use and Antimicrobial Resistance: A Popula-
tion Perspective,” by M. Lipsitch and M.H. Samore, the following
references appeared out of order: nos. 10, 14, and 19. The corrected
version appears online at http://www.cdc.gov/ncidod/EID/vol8no4/
01-0312.htm . We regret any confusion this error may have caused.
Correction, Vol. 8, No. 4
In the Letter to the Editor “O157:H7 Shiga Toxin-Producing
Escherichia coli Strains Associated with Sporadic Cases of Diarrhea
in São Paulo, Brazil,” by Kinue Irino et al., reference no. 1 was inad-
vertently omitted. That reference is
Griffin P, Tauxe RV. The epidemiology of infections caused by
Escherichia coli O157:H7, other enterohemorrhagic E. coli, and the
associated hemolytic uremic syndrome. Epidemiol Rev 1991;13:60-
98.  
References in the text should be renumbered accordingly. The
corrected version appears online at  http://www.cdc/gov/ncidod/EID/
vol8no4/01-0490.htm.  We regret any confusion this error may have
caused.
Correction, Vol. 8, No. 2
In the article “Epidemiology of Burkholderia cepacia Complex
in Patients with Cystic Fibrosis, Canada” by David P. Speert et al., an
error was made in calculations for Table 2 on page 184. The cor-
rected table appears below and online at http://www.cdc.gov/ncidod/
eid/vol8no2/01-0163.htm. 
In addition, the corrected percentages appear in two sentences
from the results section on page 183, as follows: Most isolates
(82.5%) were from genomovar III and included all strains that clus-
tered in individual centers and appeared to be transmitted from
patient to patient. Approximately 10% of infected patients were
infected with B. multivorans (genomovar II), but there was little evi-
dence among these isolates of genotypic clustering as determined by
RAPD and PFGE.
We regret any confusion this error may have caused.
Table. Antibiotic sensitivity patterns for three enterobacteria iso-
lated from patients with HIV-related persistent diarrhea in Zambia
Antimicrobial 
agenta
Nontyphoidal 
salmonellae
Shigella 
flexneri
Shigella 
dysenteriae
No. sensitive (%)  No.  sensitive (%) No. sensitive (%)
Tetracycline 37 (23)   2 (6) 3 (16)
Chlorampheni-
col
  36 (23) 7 (23) 8 (42)
Gentamicin 119 (75) 24 (77) 18 (95)
Sulphamethox-
azole-trimethop-
rim
  25 (16) 3 (10) 0 (0)
Amoxycillin   74 (47) 9 (29) 7 (37)
Amoxycillin-
clavulanic acid
  95 (60) 27 (87) 12 (63)
Cephalexin 105 (66) 23 (74) 17 (89)
Cefuroxime   93 (59) 11 (35) 16 (84)
Cefotaxime 149 (94) 28 (90) 19 (100)
Nalidixic acid 107 (68) 31 (100) 19 (100)
Ciprofloxacin 157 (99) 30 (97) 18 (95)
Erythromycin   22 (14) 0 (0) 4 (21)
Azithromycin   64 (93) 9 (100) 19 (100)
aOne hundred fifty-eight isolates of nontyphoidal salmonellae, 31 of S. flexneri, and 19 
of S. dysenteriae were tested against all these antimicrobial agents, except for azithro-
mycin, against which 69, 9, and 19 isolates were tested, respectively.
Table 2. Genomovar or species of Burkholderia cepacia complex or 
phenotypically similar isolates from cystic fibrosis patients in Canada
Species or genomovar
No. of patients infected with 
species or genomovara
Percentage of 
patients (%)
Genomovar I 1 0.2
Burkholderia  multi-
vorans (genomovar II)
43 9.6
Genomovar III 369 82.5
Burkholderia stabilis 
(genomovar IV)
17 3.8
Burkholderia vietnamien-
sis (genomovar V)
71 . 6
Burkholderia cepacia 
complex (not genomovar 
I-VII)
81 . 8
Burkholderia fungorum 10 . 2
Burkholderia gladioli 51 . 1
Ralstonia pickettii 51 . 1
Pandoraea spp. 5 1.1
Total 461a
aSome patients were counted twice if two or more different strains were recovered; 
therefore, the percentage of patients is based on a denominator of 447.
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